Alcon Inc.

74.18+0.0500+0.07%Vol 453.92K1Y Perf 45.59%
Apr 16th, 2021 16:00 DELAYED
BID70.42 ASK75.00
Open74.00 Previous Close74.13
Pre-Market- After-Market-
 - -  - -%
Target Price
72.00 
Analyst Rating
Moderate Buy 1.92
Potential %
-2.94 
Finscreener Ranking
     41.86
Insiders Trans % 3/6/12 mo.
-/-/- 
Value Ranking
★+     45.20
Insiders Value % 3/6/12 mo.
-/-/- 
Growth Ranking
★+     40.89
Insiders Shares Cnt. % 3/6/12 mo.
-/-/- 
Income Ranking
★★★★+     57.38
Market Cap36.21B 
Earnings Rating
Price Range Ratio 52W %
92.16 
Earnings Date
4th May 2021

Today's Price Range

73.6474.30

52W Range

49.7476.26

Summary:

Buy

Technical Indicators: Buy
Moving Averages: Strong Buy
Performance
1 Week
0.60%
1 Month
7.80%
3 Months
5.71%
6 Months
20.01%
1 Year
45.59%
3 Years
-
5 Years
-
10 Years
98.40%

TickerPriceChg.Chg.%
ALC74.180.05000.07
AAPL134.16-0.3400-0.25
GOOG2 297.761.10000.05
MSFT260.741.24000.48
XOM56.66-0.3200-0.56
WFC43.841.60003.79
JNJ162.241.85001.15
FB306.18-1.6400-0.53
GE13.39-0.1600-1.18
JPM153.301.13000.74
Financial StrengthValueIndustryS&P 500US Markets
1.40
2.20
0.18
0.24
-4.10
Leverage Ratio 1.50
ProfitabilityValueIndustryS&P 500US Markets
42.40
-10.90
12.00
-4.80
-9.76
RevenueValueIndustryS&P 500US Markets
4.73B
9.47
-11.60
-
Earnings HistoryEstimateReportedSurprise %
Q04 20200.420.41-2.38
Q03 20200.180.39116.67
Q02 2020-0.17-0.21-23.53
Q01 20200.390.4515.38
Q04 20190.460.45-2.17
Q03 20190.460.460.00
Q02 20190.480.47-2.08
----
Earnings Per EndEstimateRevision %Trend
----
----
----
----
Next Report Date4th May 2021
Estimated EPS Next Report0.44
Estimates Count6
EPS Growth Next 5 Years %-
Volume Overview
Volume453.92K
Shares Outstanding488.20M
Trades Count5.86K
Dollar Volume123.76M
Avg. Volume976.34K
Avg. Weekly Volume589.17K
Avg. Monthly Volume723.35K
Avg. Quarterly Volume988.44K

Alcon Inc. (NYSE: ALC) stock closed at 74.18 per share at the end of the most recent trading day (a 0.07% change compared to the prior day closing price) with a volume of 453.92K shares and market capitalization of 36.21B. Is a component of indices and it is traded on NYSE exchange. The company belongs in the Medical Devices & Instruments industry, Healthcare sector and employs 23655 people. Alcon Inc. CEO is David J. Endicott.

The one-year performance of Alcon Inc. stock is 45.59%, while year-to-date (YTD) performance is 12.43%. ALC stock has a five-year performance of %. Its 52-week range is between 49.74 and 76.26, which gives ALC stock a 52-week price range ratio of 92.16%

Alcon Inc. currently has a PE ratio of -67.20, a price-to-book (PB) ratio of 1.92, a price-to-sale (PS) ratio of 7.78, a price to cashflow ratio of 43.00, a PEG ratio of 2.32, a ROA of -1.84%, a ROC of -2.71% and a ROE of -2.67%. The company’s profit margin is -9.76%, its EBITDA margin is 12.00%, and its revenue ttm is $4.73 Billion , which makes it $9.47 revenue per share.

Of the last four earnings reports from Alcon Inc., there were 2 positive earnings surprise and 2 negative earnings surprise. The company has EPS estimate of $0.44 for the next earnings report. Alcon Inc.’s next earnings report date is 04th May 2021.

The consensus rating of Wall Street analysts for Alcon Inc. is Moderate Buy (1.92), with a target price of $72, which is -2.94% compared to the current price. The earnings rating for Alcon Inc. stock is (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Alcon Inc. has a dividend yield of 0.14% with a dividend per share of $0.11 and a payout ratio of -%.

Alcon Inc. has a Buy technical analysis rating based on Technical Indicators (ADX : 11.29, ATR14 : 1.55, CCI20 : 113.71, Chaikin Money Flow : 0.11, MACD : 0.36, Money Flow Index : 69.38, ROC : 4.86, RSI : 46.65, STOCH (14,3) : 97.69, STOCH RSI : 1.00, UO : 70.08, Williams %R : -2.31), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Alcon Inc. in the last 12-months were:

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
7 (53.85 %)
6 (46.15 %)
6 (40.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
6 (46.15 %)
7 (53.85 %)
8 (53.33 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
1 (6.67 %)
Summary RatingModerate Buy
1.92
Moderate Buy
2.08
Moderate Buy
2.33

Alcon Inc.

Alcon, headquartered in Fort Worth, Texas, is the global eyecare leader with a diverse portfolio in ophthalmology including contact lenses, eye drops, surgical equipment, and related surgical products. Novartis purchased Alcon from Nestle in 2010 and, following nine years as a Novartis subsidiary, the company was spun-off as a public company in April 2019. The company reports five distinct segments: implantables (16% of revenue), consumables (31%), equipment (9%), contact lenses (27%), and ocular health (17%). The company is geographically diversified, with 41% of revenue in the U.S. market, and the firm has a strong presence in the European Union and Japan.

CEO: David J. Endicott

Telephone: +41 589112000

Address: Chemin de Blandonnet 8, Geneva 1214, , CH

Number of employees: 23 655

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

100%0%

Bearish Bullish

59%41%

Bearish Bullish

59%41%

Bearish Bullish

56%44%

News

Stocktwits